| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |